Featured

Key Finding Identifies Most Promising Drug for Targeted Clinical Trial

January 24th, 2017|

As reported in Neuro-Oncology Magazine (January 12th, 2017), with leadership from the Dana Farber Cancer Institute’s Dr. Charles Stiles and up and coming researcher, Dr. Sarah Buhrlage, ground-breaking science […]

Comments Off on Key Finding Identifies Most Promising Drug for Targeted Clinical Trial

Precision Medicine Impacts Pediatric Brain Cancer Treatment

January 19th, 2017|

Precision medicine—in which diagnosis and treatments are keyed to the genetic susceptibilities of individual cancers—has advanced to the point where it can now impact the care of a majority […]

Comments Off on Precision Medicine Impacts Pediatric Brain Cancer Treatment

Brain Cancer Now the Leading Childhood Cancer Killer

September 21st, 2016|

According to newly released data by the U.S. Centers for Disease Control and Prevention (CDC), brain cancer is now the deadliest childhood cancer. For the first time, brain cancer […]

Comments Off on Brain Cancer Now the Leading Childhood Cancer Killer

AKBTC Joins Solving Kids’ Cancer and the Ty Louis Campbell Foundation to Fund Phase 1 Clinical Trial

August 10th, 2016|

When 3 like-minded childhood cancer charities partner together, anything is possible! In the most recent collaboration, three New York based pediatric cancer charities, A Kids’ Brain Tumor Cure, The […]

Comments Off on AKBTC Joins Solving Kids’ Cancer and the Ty Louis Campbell Foundation to Fund Phase 1 Clinical Trial

Phase 1/II Study of MEK162 for Children with Ras/Raf Pathway Activated Tumors

August 10th, 2016|

With the discovery of new targets, the pipeline for PLGA clinical trials is ramping up to be more productive than ever before.  The newest PLGA clinical trial, entitled Phase […]

Comments Off on Phase 1/II Study of MEK162 for Children with Ras/Raf Pathway Activated Tumors

Molecular Analysis of Pediatric Brain Tumors Identifies microRNAs in Pilocytic Astrocytomas that Target the MAPK and NF-κB Pathways

July 7th, 2016|

In this A Kids’ Brain Tumor Cure (PLGA Foundation) funded project, Dr. Denise Sheer and colleagues show that microRNAs that regulate critical signalling pathways in pilocytic astrocytomas are more […]

Comments Off on Molecular Analysis of Pediatric Brain Tumors Identifies microRNAs in Pilocytic Astrocytomas that Target the MAPK and NF-κB Pathways

Genetic Cause Identified in Rare PLGG Brain Tumor

February 3rd, 2016|

Another success in the pediatric brain tumor research arena, as Dana Farber Cancer Institute and Children’s Hospital of Philadelphia researchers announce that a recent collaborative study has identified a […]

Comments Off on Genetic Cause Identified in Rare PLGG Brain Tumor

Pediatric Low-grade Gliomas With CRAF Fusions May Require Differential and Combinatorial Targeted Therapies

November 17th, 2015|

Payal Jain, graduate PhD student in Dr. Adam Resnick’s lab at the Children’s Hospital of Philadelphia, recently presented an abstract at the AACR-NCI-EORTC International Conference on Molecular Targets and […]

Comments Off on Pediatric Low-grade Gliomas With CRAF Fusions May Require Differential and Combinatorial Targeted Therapies

Webinar: Pediatric Brain Tumor Survivors – Supporting Their Educational Needs

September 8th, 2015|

With the advancement of medical treatments for childhood cancer, survival rates for pediatric cancer patients have increased significantly. As long-term survival rates increase, however, the neurocognitive deficits associated with […]

Comments Off on Webinar: Pediatric Brain Tumor Survivors – Supporting Their Educational Needs

Camp Sunshine: 2015 Recap & 2016 Registration

August 17th, 2015|

On July 19, 2015, 35 families traveled to beautiful Camp Sunshine in Casco, Maine for a week of fun and fellowship within the LGG brain tumor community. With over […]

Comments Off on Camp Sunshine: 2015 Recap & 2016 Registration